Jim Cramer Weighs In On Philip Morris And NewLink Genetics

On CNBC's "Mad Money", Jim Cramer said he doesn't like to recommend the tobacco stocks, but he thinks that Philip Morris International Inc. PM is oversold. He explained that the dividend yield for the stock is now 4 percent.

It's hard for Cramer to recommend NewLink Genetics Corp NLNK because it's a pre-clinical early drug stock. He added that Bank Of America's analysts are way too bullish with a price target of $22.